Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S W Pipe

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2009
Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia AL A Valentino, M Recht, J Dipaola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2016
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxisL A Valentino, S W Pipe, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia AS Kasuda, A Kubo, Y Sakurai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2018
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysisM Carcao, A Shapiro, J M Staber, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2009
Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia AL A Valentino, M Recht, J Dipaola, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 2, 2016
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxisL A Valentino, S W Pipe, P W Collins, et al.
Journal of Thrombosis and Haemostasis : JTH|May 20, 2008
Establishment of embryonic stem cells secreting human factor VIII for cell-based treatment of hemophilia AS Kasuda, A Kubo, Y Sakurai, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 14, 2018
Recombinant factor VIII Fc fusion protein for immune tolerance induction in patients with severe haemophilia A with inhibitors-A retrospective analysisM Carcao, A Shapiro, J M Staber, et al.
Pageof 5